Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Lung Neoplasms

Lung Diseases

Respiratory Tract Neoplasms

Thoracic Neoplasms

Respiratory Tract Diseases

Providers in this arm will continue to provide care as usual during lung cancer screening, with no intervention from the study team.

Providers in this arm will receive guidance from the study team about offering lung cancer screening patients proactive cessation care, including cessation medications and behavioral telephone counseling.

For patients of providers assigned to the proactive study group, a local coordinator will review the patient's cessation medication history. If the patient is not currently being provided cessation support medication, the coordinator will enter a note and unsigned order for the provider about the recommended medication indicated by VA formulary guidelines.

Unsigned note to provider about cessation medication prescription

Patients of providers assigned to the proactive study group will be contacted by specially trained counselors at the VA Quitline. Counselors will attempt to provide two sessions of proactive telephone support.

Proactive Telephone Counseling from VA Quitline

Steven B. Zeliadt, PhD MPH

This pragmatic trial will evaluate the value of routinely providing proactive smoking cessation support to current smokers as a part of participating in lung cancer screening within Veterans Health Administration.

This trial is a pragmatic randomized trial targeting the care of current smokers who are participating in lung cancer screening at two VA sites. Primary care providers at these sites will be randomized, and half will be offered tools to help integrate proactive smoking cessation support into the lung cancer screening process. Key proactive elements include proactive telephone outreach to all current smokers by a VA Quitline counselor that follows mailed results letters, and providing providers guidance in offering proactive cessation medication support as part of the lung cancer screening process.

Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment

The investigators anticipate publishing the findings alongside other similar trials funded by NCI through the Smoking Cessation within the Context of Lung Cancer Screening (SCALE) collaboration, with journals that will likely require concurrent publication of de-identified datasets.

The primary outcome measure is self-reported abstinence from smoking 12 months after lung cancer screening, using information obtained from study surveys and electronic medical records

Provider surveys will assess acceptance of and satisfaction with the proactive care approach among primary care clinicians referring Veterans for lung cancer screening

Costs of implementing the proactive care approach will be monitored and analyzed, including intervention staff effort, provider time, costs of telephone counseling, and pharmacotherapy costs

Patient surveys will assess satisfaction with VA Quitline telephone counseling

Surveys will assess patient motivation to quit smoking

Surveys will assess patients' perceived susceptibility to the harmful effects of smoking and perception of screening as protective

Surveys will assess patients' self-efficacy for quitting smoking

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment	NCT03612804	Smoking Reducti... Tobacco Use Tobacco Smoking Tomography Lung Diseases Lung Neoplasms	Unsigned note t... Proactive Telep...	- 80 Years	VA Office of Research and Development
Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment	NCT03612804	Smoking Reducti... Tobacco Use Tobacco Smoking Tomography Lung Diseases Lung Neoplasms	Unsigned note t... Proactive Telep...	- 80 Years	VA Office of Research and Development

Spots Global Cancer Trial Database for proactive telephone counseling from va quitline